These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
117 related items for PubMed ID: 7905381
21. Aldrin epoxidation, a highly sensitive indicator specific for cytochrome P-450-dependent mono-oxygenase activities. Wolff T, Deml E, Wanders H. Drug Metab Dispos; 1979; 7(5):301-5. PubMed ID: 40770 [Abstract] [Full Text] [Related]
22. Cytochrome P450 responsible for the stereoselective S-oxidation of flosequinan in hepatic microsomes from rats and humans. Kashiyama E, Yokoi T, Odomi M, Funae Y, Inoue K, Kamataki T. Drug Metab Dispos; 1997 Jun; 25(6):716-24. PubMed ID: 9193873 [Abstract] [Full Text] [Related]
23. Detection and localization of CYP1A1/CYP1A2 in murine liver: electrophoresis, immunoblotting and immunocytochemistry. Oladapo OO, Forkert PG. Afr J Med Med Sci; 1995 Dec; 24(4):395-402. PubMed ID: 8886157 [Abstract] [Full Text] [Related]
24. Enzyme-kinetic and immunochemical characteristics of mouse cDNA-expressed, microsomal, and purified CYP1A1 and CYP1A2. Tsyrlov IB, Goldfarb IS, Gelboin HV. Arch Biochem Biophys; 1993 Dec; 307(2):259-66. PubMed ID: 8274012 [Abstract] [Full Text] [Related]
25. Regulation of cytochrome P4501A1 expression in rat small intestine. Zhang QY, Wikoff J, Dunbar D, Fasco M, Kaminsky L. Drug Metab Dispos; 1997 Jan; 25(1):21-6. PubMed ID: 9010625 [Abstract] [Full Text] [Related]
26. Site-selective differences in cytochrome P450 isoform activities. Comparison of expression in rat and rhesus monkey lung and induction in rats. Lee C, Watt KC, Chang AM, Plopper CG, Buckpitt AR, Pinkerton KE. Drug Metab Dispos; 1998 May; 26(5):396-400. PubMed ID: 9571220 [Abstract] [Full Text] [Related]
27. Ring hydroxylation of [o-3H]methoxychlor as a probe for liver microsomal CYP2B activity: potential for in vivo CYP2B assay. Stresser DM, Dehal SS, Kupfer D. Anal Biochem; 1996 Jan 01; 233(1):100-7. PubMed ID: 8789153 [Abstract] [Full Text] [Related]
28. Metabolic activation of dacarbazine by human cytochromes P450: the role of CYP1A1, CYP1A2, and CYP2E1. Reid JM, Kuffel MJ, Miller JK, Rios R, Ames MM. Clin Cancer Res; 1999 Aug 01; 5(8):2192-7. PubMed ID: 10473105 [Abstract] [Full Text] [Related]
29. Uroporphyrinogen oxidation catalyzed by human cytochromes P450. Sinclair PR, Gorman N, Tsyrlov IB, Fuhr U, Walton HS, Sinclair JF. Drug Metab Dispos; 1998 Oct 01; 26(10):1019-25. PubMed ID: 9763408 [Abstract] [Full Text] [Related]
30. Relationship of cytochrome P450 activity to Clara cell cytotoxicity. II. Comparison of stereoselectivity of naphthalene epoxidation in lung and nasal mucosa of mouse, hamster, rat and rhesus monkey. Buckpitt A, Buonarati M, Avey LB, Chang AM, Morin D, Plopper CG. J Pharmacol Exp Ther; 1992 Apr 01; 261(1):364-72. PubMed ID: 1560380 [Abstract] [Full Text] [Related]
31. Inhibition of in vitro aflatoxin B1-DNA binding in rainbow trout by CYP1A inhibitors: alpha-naphthoflavone, beta-naphthoflavone and trout CYP1A1 peptide antibody. Takahashi N, Miranda CL, Henderson MC, Buhler DR, Williams DE, Bailey GS. Comp Biochem Physiol C Pharmacol Toxicol Endocrinol; 1995 Mar 01; 110(3):273-80. PubMed ID: 7599976 [Abstract] [Full Text] [Related]
32. Epoxidation of acrylonitrile by rat and human cytochromes P450. Kedderis GL, Batra R, Koop DR. Chem Res Toxicol; 1993 Mar 01; 6(6):866-71. PubMed ID: 8117926 [Abstract] [Full Text] [Related]
34. Cytochrome P-450-catalyzed asymmetric epoxidation of simple prochiral and chiral aliphatic alkenes: species dependence and effect of enzyme induction on enantioselective oxirane formation. Wistuba D, Nowotny HP, Träger O, Schurig V. Chirality; 1989 Aug 01; 1(2):127-36. PubMed ID: 2642041 [Abstract] [Full Text] [Related]
35. Human hepatic CYP1A1 and CYP1A2 content, determined with specific anti-peptide antibodies, correlates with the mutagenic activation of PhIP. Murray BP, Edwards RJ, Murray S, Singleton AM, Davies DS, Boobis AR. Carcinogenesis; 1993 Apr 01; 14(4):585-92. PubMed ID: 8472319 [Abstract] [Full Text] [Related]
36. In vitro and in vivo biotransformations of the naphthalenic lignan lactone 5-lipoxygenase inhibitor, L-702,539. Chauret N, Li C, Ducharme Y, Trimble LA, Yergey JA, Ramachandran C, Nicoll-Griffith DA. Drug Metab Dispos; 1995 Jan 01; 23(1):65-71. PubMed ID: 7720527 [Abstract] [Full Text] [Related]
37. Cytochrome P-450-dependent oxidation of the 17 alpha-ethynyl group of synthetic steroids. D-homoannulation or enzyme inactivation. Schmid SE, Au WY, Hill DE, Kadlubar FF, Slikker W. Drug Metab Dispos; 1983 Jan 01; 11(6):531-6. PubMed ID: 6140135 [Abstract] [Full Text] [Related]
38. Role of cytochrome P450 1A2 in bilirubin degradation Studies in Cyp1a2 (-/-) mutant mice. Zaccaro C, Sweitzer S, Pipino S, Gorman N, Sinclair PR, Sinclair JF, Nebert DW, De Matteis F. Biochem Pharmacol; 2001 Apr 01; 61(7):843-9. PubMed ID: 11274970 [Abstract] [Full Text] [Related]
39. Inhibition of ethoxyresorufin deethylase activity by natural flavonoids in human and rat liver microsomes. Siess MH, Le Bon AM, Suschetet M, Rat P. Food Addit Contam; 1990 Apr 01; 7 Suppl 1():S178-81. PubMed ID: 2262030 [Abstract] [Full Text] [Related]
40. Monooxygenase-catalyzed aldrin epoxidation and dihydroisodrin hydroxylation in monkey liver needle-biopsy specimens. Assay and properties. Krieger RI, Gee SJ, Miller JL, Thongsinthusak. Drug Metab Dispos; 1976 Apr 01; 4(1):28-34. PubMed ID: 3398 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]